369 related articles for article (PubMed ID: 30738930)
1. Cannabis use behaviors and prevalence of anxiety and depressive symptoms in a cohort of Canadian medicinal cannabis users.
Turna J; Simpson W; Patterson B; Lucas P; Van Ameringen M
J Psychiatr Res; 2019 Apr; 111():134-139. PubMed ID: 30738930
[TBL] [Abstract][Full Text] [Related]
2. [Prevalence of psychiatric disorders in French general practice using the patient health questionnaire: comparison with GP case-recognition and psychotropic medication prescription].
Norton J; de Roquefeuil G; David M; Boulenger JP; Ritchie K; Mann A
Encephale; 2009 Dec; 35(6):560-9. PubMed ID: 20004287
[TBL] [Abstract][Full Text] [Related]
3. Is cannabis treatment for anxiety, mood, and related disorders ready for prime time?
Turna J; Patterson B; Van Ameringen M
Depress Anxiety; 2017 Nov; 34(11):1006-1017. PubMed ID: 28636769
[TBL] [Abstract][Full Text] [Related]
4. Characterization of mental health in cannabis dispensary users, using structured clinical interviews and standardized assessment instruments.
Yau JC; Yu SM; Panenka WJ; Pearce H; Gicas KM; Procyshyn RM; MacCallum C; Honer WG; Barr AM
BMC Psychiatry; 2019 Nov; 19(1):335. PubMed ID: 31675939
[TBL] [Abstract][Full Text] [Related]
5. Cannabis use in cancer: a survey of the current state at BC Cancer before recreational legalization in Canada.
Hawley P; Gobbo M
Curr Oncol; 2019 Aug; 26(4):e425-e432. PubMed ID: 31548810
[TBL] [Abstract][Full Text] [Related]
6. Cannabis in patients with Parkinson's disease in Argentina. A cross sectional study.
Micheli FE; Groppo J; Contartese ML; Baccaglio PG; Borisonik LN; Lakos C; Barros JP; Maiola RP; Arakaki T; Garretto NS; Giannaula RJ; Pecci MC
Parkinsonism Relat Disord; 2020 Sep; 78():66-67. PubMed ID: 32739838
[TBL] [Abstract][Full Text] [Related]
7. [Sociodemographic profiles, addictive and mental comorbidity in cannabis users in an outpatient specific setting].
Guillem E; Pelissolo A; Vorspan F; Bouchez-Arbabzadeh S; Lépine JP
Encephale; 2009 Jun; 35(3):226-33. PubMed ID: 19540408
[TBL] [Abstract][Full Text] [Related]
8. Cannabis Use for Medicinal Purposes among Canadian University Students.
Smith JM; Mader J; Szeto ACH; Arria AM; Winters KC; Wilkes TCR
Can J Psychiatry; 2019 May; 64(5):351-355. PubMed ID: 30602305
[TBL] [Abstract][Full Text] [Related]
9. UK Medical Cannabis Registry: an analysis of clinical outcomes of medicinal cannabis therapy for generalized anxiety disorder.
Ergisi M; Erridge S; Harris M; Kawka M; Nimalan D; Salazar O; Loupasaki K; Ali R; Holvey C; Coomber R; Platt M; Rucker JJ; Sodergren MH
Expert Rev Clin Pharmacol; 2022 Apr; 15(4):487-495. PubMed ID: 34937473
[TBL] [Abstract][Full Text] [Related]
10. A Survey of Cannabis Acute Effects and Withdrawal Symptoms: Differential Responses Across User Types and Age.
Sexton M; Cuttler C; Mischley LK
J Altern Complement Med; 2019 Mar; 25(3):326-335. PubMed ID: 30383388
[TBL] [Abstract][Full Text] [Related]
11. Clinical characteristics and treatment outcomes of patients with major depressive disorder and comorbid anxiety disorders - results from a European multicenter study.
Dold M; Bartova L; Souery D; Mendlewicz J; Serretti A; Porcelli S; Zohar J; Montgomery S; Kasper S
J Psychiatr Res; 2017 Aug; 91():1-13. PubMed ID: 28284107
[TBL] [Abstract][Full Text] [Related]
12. The burden of generalized anxiety disorder in Canada.
Pelletier L; O'Donnell S; McRae L; Grenier J
Health Promot Chronic Dis Prev Can; 2017 Feb; 37(2):54-62. PubMed ID: 28273041
[TBL] [Abstract][Full Text] [Related]
13. [Comorbidity in 207 cannabis users in a specific outpatient setting].
Guillem E; Arbabzadeh-Bouchez S; Vorspan F; Bellivier F
Encephale; 2015 Jun; 41 Suppl 1():S7-12. PubMed ID: 25123065
[TBL] [Abstract][Full Text] [Related]
14. Cannabis based medicines and cannabis dependence: A critical review of issues and evidence.
Schlag AK; Hindocha C; Zafar R; Nutt DJ; Curran HV
J Psychopharmacol; 2021 Jul; 35(7):773-785. PubMed ID: 33593117
[TBL] [Abstract][Full Text] [Related]
15. Clinical correlates and symptom patterns of anxious depression among patients with major depressive disorder in STAR*D.
Fava M; Alpert JE; Carmin CN; Wisniewski SR; Trivedi MH; Biggs MM; Shores-Wilson K; Morgan D; Schwartz T; Balasubramani GK; Rush AJ
Psychol Med; 2004 Oct; 34(7):1299-308. PubMed ID: 15697056
[TBL] [Abstract][Full Text] [Related]
16. How effective and safe is medical cannabis as a treatment of mental disorders? A systematic review.
Hoch E; Niemann D; von Keller R; Schneider M; Friemel CM; Preuss UW; Hasan A; Pogarell O
Eur Arch Psychiatry Clin Neurosci; 2019 Feb; 269(1):87-105. PubMed ID: 30706168
[TBL] [Abstract][Full Text] [Related]
17. Clinical and functional outcomes of cannabis use among individuals with anxiety disorders: A 3-year population-based longitudinal study.
Feingold D; Rehm J; Factor H; Redler A; Lev-Ran S
Depress Anxiety; 2018 Jun; 35(6):490-501. PubMed ID: 29486095
[TBL] [Abstract][Full Text] [Related]
18. High Manifestations of Mental Distress in Arabic Asylum Seekers Accommodated in Collective Centers for Refugees in Germany.
Georgiadou E; Morawa E; Erim Y
Int J Environ Res Public Health; 2017 Jun; 14(6):. PubMed ID: 28590438
[TBL] [Abstract][Full Text] [Related]
19. Generalized Anxiety Disorder 7-Item (GAD-7) Scores in Medically Authorized Cannabis Patients-Ontario and Alberta, Canada.
Lee C; Round JM; Hanlon JG; Hyshka E; Dyck JRB; Eurich DT
Can J Psychiatry; 2022 Jun; 67(6):470-480. PubMed ID: 34520280
[TBL] [Abstract][Full Text] [Related]
20. Cannabis use and its association with psychopathological symptoms in a Swiss adult population: a cross-sectional analysis.
Mosandl CF; Baltes-Flückiger L; Kronschnabel J; Meyer M; Guessoum A; Herrmann O; Vogel M; Walter M; Pichler EM
Front Public Health; 2024; 12():1356988. PubMed ID: 38841675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
